{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:38:03Z","timestamp":1790699883700,"version":"4.1.0"},"reference-count":37,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2022,6,24]]},"DOI":"10.1253\/circj.cj-21-0529","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T22:09:07Z","timestamp":1646863747000},"page":"1092-1101","source":"Crossref","is-referenced-by-count":24,"title":["Myocardial T-Lymphocytes as a Prognostic Risk-Stratifying Marker of Dilated Cardiomyopathy\u3000\u2015 Results of the Multicenter Registry to Investigate Inflammatory Cell Infiltration in Dilated Cardiomyopathy in Tissues of Endomyocardial Biopsy (INDICATE Study) \u2015"],"prefix":"10.1253","volume":"86","author":[{"given":"Keiko","family":"Ohta-Ogo","sequence":"first","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Sugano","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keiyu Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soshiro","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Komori","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Jichi Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Eguchi","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Saitama Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Dohi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Nephrology, Mie University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Yokokawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Fukushima Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Kanamori","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Gifu University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyuki","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Saitama Medical University International Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazufumi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceuticals"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genzou","family":"Takemura","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Asahi University School of Dentistry"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Anzai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiaki","family":"Hiroe","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Center for Global Health and Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinta","family":"Hatakeyama","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatsue","family":"Ishibashi-Ueda","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Imanaka-Yoshida","sequence":"additional","affiliation":[{"name":"Department of Pathology and Matrix Biology, Mie University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. <i>Eur Heart J<\/i> 2008; 29: 270\u2013276.","DOI":"10.1093\/eurheartj\/ehm342"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Braunwald E. Cardiomyopathies: An overview. <i>Circ Res<\/i> 2017; 121: 711\u2013721.","DOI":"10.1161\/CIRCRESAHA.117.311812"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Kitaoka H, Tsutsui H, Kubo T, Ide T, Chikamori T, Fukuda K, et al. JCS\/JHFS 2018 guideline on the diagnosis and treatment of cardiomyopathies. <i>Circ J<\/i> 2021; 85: 1590\u20131689.","DOI":"10.1253\/circj.CJ-20-0910"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O\u2019Connell J, et al. Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. <i>Circulation<\/i> 1996; 93: 841\u2013842.","DOI":"10.1161\/01.CIR.93.5.841"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kawai C. From myocarditis to cardiomyopathy: Mechanisms of inflammation and cell death: Learning from the past for the future. <i>Circulation<\/i> 1999; 99: 1091\u20131100.","DOI":"10.1161\/01.CIR.99.8.1091"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. <i>Eur Heart J<\/i> 2013; 34: 2636\u20132648; 2648a\u20132648d.","DOI":"10.1093\/eurheartj\/eht210"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Maisch B, Portig I, Ristic A, Hufnagel G, Pankuweit S. Definition of inflammatory cardiomyopathy (myocarditis): On the way to consensus. A status report. <i>Herz<\/i> 2000; 25: 200\u2013209.","DOI":"10.1007\/s000590050007"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Imanaka-Yoshida K. Inflammation in myocardial disease: From myocarditis to dilated cardiomyopathy. <i>Pathol Int<\/i> 2020; 70: 1\u201311.","DOI":"10.1111\/pin.12868"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Japanese Circulation Society (JCS) Task Force Committee on Chronic Myocarditis. Guideline for diagnosing chronic myocarditis. <i>Jpn Circ J<\/i> 1996; 60: 263\u2013264.","DOI":"10.1253\/jcj.60.263"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. JCS Joint Working Group. Guidelines for diagnosis and treatment of myocarditis (JCS 2009): Digest version. <i>Circ J<\/i> 2011; 75: 734\u2013743.","DOI":"10.1253\/circj.CJ-88-0008"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Tschope C, Cooper LT, Torre-Amione G, Van Linthout S. Management of myocarditis-related cardiomyopathy in adults. <i>Circ Res<\/i> 2019; 124: 1568\u20131583.","DOI":"10.1161\/CIRCRESAHA.118.313578"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hirono K, Takarada S, Okabe M, Miyao N, Nakaoka H, Ibuki K, et al. Clinical significance of chronic myocarditis: Systematic review and meta-analysis. <i>Heart and Vessels<\/i> 2022; 37: 300\u2013314.","DOI":"10.1007\/s00380-021-01914-y"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Frustaci A, Chimenti C. Immunosuppressive therapy in myocarditis. <i>Circ J<\/i> 2015; 79: 4\u20137.","DOI":"10.1253\/circj.CJ-14-1192"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Merken J, Hazebroek M, Van Paassen P, Verdonschot J, Van Empel V, Knackstedt C, et al. Immunosuppressive therapy improves both short- and long-term prognosis in patients with virus-negative nonfulminant inflammatory cardiomyopathy. <i>Circ Heart Fail<\/i> 2018; 11: e004228.","DOI":"10.1161\/CIRCHEARTFAILURE.117.004228"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tsch\u00f6pe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions. <i>Nat Rev Cardiol<\/i> 2021; 18: 169\u2013193.","DOI":"10.1038\/s41569-020-00435-x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. <i>Nat Rev Cardiol<\/i> 2020; 17: 269\u2013285.","DOI":"10.1038\/s41569-019-0315-x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Buja LM, Ottaviani G, Ilic M, Zhao B, Lelenwa LC, Segura AM, et al. Clinicopathological manifestations of myocarditis in a heart failure population. <i>Cardiovasc Pathol<\/i> 2020; 45: 107190.","DOI":"10.1016\/j.carpath.2019.107190"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Sotiriou E, Heiner S, Jansen T, Brandt M, Schmidt KH, Kreitner KF, et al. Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all-comer population of patients with heart failure: A retrospective analysis. <i>ESC Heart Fail<\/i> 2018; 5: 630\u2013641.","DOI":"10.1002\/ehf2.12296"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Bennett MK, Gilotra NA, Harrington C, Rao S, Dunn JM, Freitag TB, et al. Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000\u20132009. <i>Circ Heart Fail<\/i> 2013; 6: 676\u2013684.","DOI":"10.1161\/CIRCHEARTFAILURE.112.000087"},{"key":"20","unstructured":"20. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, et al. Myocarditis: A histopathologic definition and classification. <i>Am J Cardiovasc Pathol<\/i> 1987; 1: 3\u201314."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Baughman KL. Diagnosis of myocarditis: Death of Dallas criteria. <i>Circulation<\/i> 2006; 113: 593\u2013595.","DOI":"10.1161\/CIRCULATIONAHA.105.589663"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Katzmann JL, Schlattmann P, Rigopoulos AG, Noutsias E, Bigalke B, Pauschinger M, et al. Meta-analysis on the immunohistological detection of inflammatory cardiomyopathy in endomyocardial biopsies. <i>Heart Fail Rev<\/i> 2020; 25: 277\u2013294.","DOI":"10.1007\/s10741-019-09835-9"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Leone O, Veinot JP, Angelini A, Baandrup UT, Basso C, Berry G, et al. 2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. <i>Cardiovasc Pathol<\/i> 2012; 21: 245\u2013274.","DOI":"10.1016\/j.carpath.2011.10.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Imanaka-Yoshida K. Tenascin-C in heart diseases: The role of inflammation. <i>Int J Mol Sci<\/i> 2021; 22: 5828.","DOI":"10.3390\/ijms22115828"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. <i>Circulation<\/i> 1980; 62: 1054\u20131061.","DOI":"10.1161\/01.CIR.62.5.1054"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nakayama T, Sugano Y, Yokokawa T, Nagai T, Matsuyama TA, Ohta-Ogo K, et al. Clinical impact of the presence of macrophages in endomyocardial biopsies of patients with dilated cardiomyopathy. <i>Eur J Heart Fail<\/i> 2017; 19: 490\u2013498.","DOI":"10.1002\/ejhf.767"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yokokawa T, Sugano Y, Nakayama T, Nagai T, Matsuyama TA, Ohta-Ogo K, et al. Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy. <i>Eur J Heart Fail<\/i> 2016; 18: 375\u2013385.","DOI":"10.1002\/ejhf.464"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Wada Y, Aiba T, Matsuyama TA, Nakajima I, Ishibashi K, Miyamoto K, et al. Clinical and pathological impact of tissue fibrosis on lethal arrhythmic events in hypertrophic cardiomyopathy patients with impaired systolic function. <i>Circ J<\/i> 2015; 79: 1733\u20131741.","DOI":"10.1253\/circj.CJ-15-0104"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Chang C, Hsieh MK, Chang WY, Chiang AJ, Chen J. Determining the optimal number and location of cutoff points with application to data of cervical cancer. <i>PLoS One<\/i> 2017; 12: e0176231.","DOI":"10.1371\/journal.pone.0176231"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. <i>Bone Marrow Transplant<\/i> 2013; 48: 452\u2013458.","DOI":"10.1038\/bmt.2012.244"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Tsukada B, Terasaki F, Shimomura H, Otsuka K, Otsuka K, Katashima T, et al. High prevalence of chronic myocarditis in dilated cardiomyopathy referred for left ventriculoplasty: Expression of tenascin C as a possible marker for inflammation. <i>Hum Pathol<\/i> 2009; 40: 1015\u20131022.","DOI":"10.1016\/j.humpath.2008.12.017"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, et al. Predictors of outcome in patients with suspected myocarditis. <i>Circulation<\/i> 2008; 118: 639\u2013648.","DOI":"10.1161\/CIRCULATIONAHA.108.769489"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: The TIMIC study. <i>Eur Heart J<\/i> 2009; 30: 1995\u20132002.","DOI":"10.1093\/eurheartj\/ehp249"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: An expert consensus document. <i>Circ Heart Fail<\/i> 2020; 13: e007405.","DOI":"10.1161\/CIRCHEARTFAILURE.120.007405"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Blanton RM, Carrillo-Salinas FJ, Alcaide P. T-cell recruitment to the heart: Friendly guests or unwelcome visitors? <i>Am J Physiol Heart Circ Physiol<\/i> 2019; 317: H124\u2013H140.","DOI":"10.1152\/ajpheart.00028.2019"},{"key":"36","unstructured":"36. Edwards WD, Holmes DR Jr, Reeder GS. Diagnosis of active lymphocytic myocarditis by endomyocardial biopsy: Quantitative criteria for light microscopy. <i>Mayo Clin Proc<\/i> 1982; 57: 419\u2013425."},{"key":"37","unstructured":"37. Foley DA, Edwards WD. Quantitation of leukocytes in endomyocardial tissue from 100 normal human hearts at autopsy: Implications for diagnosis of myocarditis from biopsy specimens of living patients. <i>Am J Cardiovasc Pathol<\/i> 1988; 2: 145\u2013149."}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/86\/7\/86_CJ-21-0529\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:19:20Z","timestamp":1715231960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/86\/7\/86_CJ-21-0529\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-21-0529","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"article-number":"CJ-21-0529"}}